Active Ingredient(s): Arsenic Trioxide
FDA Approved: * September 25, 2000
Pharm Company: * CEPHALON
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Trisenox Overview

Arsenic trioxide is an inorganic compound with the formula As2O3. This commercially important oxide of arsenic is the main precursor to other arsenic compounds, including organoarsenic compounds. Approximately 50,000 tonnes are produced annually.[4] Many applications are controversial given the high toxicity of arsenic compounds. Contents 1 Uses 1.1 Medical applications 2 Toxicology 3 Production and occurrence 4 Properties and reactions 5 Structure 6 Environmental probl...

Read more Trisenox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Trisenox Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Arsenic Trioxide
  • Injection: 10ml, 1mg/ml, 2mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Trisenox: (2 results)

Sorted by National Drug Code
  • 63459-600 Trisenox 1 mg/ml Intravenous Injection, Solution by Cephalon, Inc.
  • 63459-601 Trisenox 2 mg/ml Intravenous Injection, Solution by Cephalon, Inc.

Other drugs which contain Arsenic Trioxide or a similar ingredient: (1 result)

Related Trisenox Topics:

where to but Trisenox
I have relative in Indonesia need to have Trisenox urently, where to buy this drug ## I doubt very much that you can jus... 2 replies

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 August 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA